No black box warning on record for Darunavir

As of the latest FDA labeling reviewed, Darunavir (DARUNAVIR) does not carry a black box warning. Standard warnings and precautions still apply — see the full Darunavir medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Drug-induced hepatitis (e.g., acute hepatitis, cytolytic hepatitis) has been reported with darunavir/ritonavir. Monitor liver function before and during therapy, especially in patients with underlying chronic hepatitis, cirrhosis or in patients who have pre-treatment elevations of transaminases. Post-marketing cases of liver injury, including some fatalities, have been r

No black box warning on record for Darunavir

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Drug-induced hepatitis (e.g., acute hepatitis, cytolytic hepatitis) has been reported with darunavir/ritonavir. Monitor liver function before and during therapy, especially in patients with underlying chronic hepatitis, cirrhosis or in patients who have pre-treatment elevations of transaminases. Post-marketing cases of liver injury, including some fatalities, have been r

Darunavir Black Box Warning

No black box warning on record for Darunavir

Other warnings & precautions

Darunavir Black Box Warning

No black box warning on record for Darunavir

Other warnings & precautions